Company News

Galderma Explores Expansion of Manufacturing and Innovation Footprint in Asia-Pacific

A new facility is expected to increase Galderma's manufacturing capacity by up to 350 million units per year in response to demand for science-based products.

Author Image

By: Lianna Albrizio

Associate Editor

  Galderma says it will explore opportunities to build its fifth manufacturing plant in Singapore.   Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma's manufacturing capacity by up to 350 million units per year in response to continuing demand for premium science-based products in the dermo‑cosmetics sector.   The announcement comes as part of Galderma's strategic manufacturing roadmap, aligned with the company...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters